Error message
No active batch.
Meetings
Individuals with MS have excessive rates of physical and mental health comorbidities, which can affect health-related quality of life
The link between multiple physical comorbidities and mental health comorbidities is strong among Scottish people with MS, according to findings from a cross-sectional analysis published in BMC Neurology.
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
Stem Cell Progress in Mice; Treating Progressive MS; New Website for Progressive Alliance
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Meetings
Special CMSC Meeting Edition: Exercise and Aggressive Rehabilitation; Patient Satisfaction With CCSVI; Ambitious MS Database Being Planned
This edition of MS Research Roundup concentrates on the joint meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis...
Clinical Research, Meetings, People
In a dose-ranging study of the anti-CD20 antibody ofatumumab, even incomplete depletion of peripheral B cells was associated with a reduced number of MRI brain lesions in patients with RRMS
When treating relapsing-remitting multiple sclerosis patients with anti-B cell antibodies, complete depletion of B cells is...
Clinical Research, Drug Development, Meetings
A study in a mouse model of secondary progressive multiple sclerosis suggests that a nasal vaccine that regulates innate immunity may halt clinical disease and neurodegeneration
Most multiple sclerosis patients are initially diagnosed with the relapsing-remitting form of the disease, but over time...
Laboratory Research, Meetings
Widely touted in multiple sclerosis patient communities, low-dose naltrexone does appear to improve disease scores in about half of mice with an experimentally induced version of MS. Researchers found a similar pattern of results with met-enkephalin.
A growing subculture of MS patients and clinicians has been touting low-dose...
Clinical Research, Drug Development, Laboratory Research, Meetings
In a head-to-head comparison of four MS models, one based on HSV-1 infection shows its value
It’s caused plenty of embarrassment, but the virus that triggers cold sores could also provide insight into...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
Computer analyses extract new insights from MS patient data
Since he was diagnosed with multiple sclerosis in 2007, Curtis Schreiner, a three-time U.S. Olympian in the biathlon, has...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
Tests of HIV Drug in Progress for RRMS; Statin Discovery in Progressive MS; Bench-to-Bedside MS Research Talks Online
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Meetings
A meeting sponsored by The New York Academy of Sciences
Demyelination and Remyelination: From Mechanism to Therapy
June 26, 2014
The New York Academy of Sciences
New York, NY
Pages
